RxDoctor Payments Data

Leigh Fleury, PA

Physician Assistant · Fort Worth, TXNPI 1942590450

Payments from drug & device makers

$3,439in general payments, 2019–2025

Across 245 payments — averaging $14.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$362
  • Amgen$285
  • AstraZeneca$201
  • Bayer$137
  • Almatica Pharma LLC$125
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$3,439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,439 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$12,870
Medicare patients
75
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide14$23,151
TrulicityDulaglutide13$15,982
XareltoRivaroxaban12$5,991
Duloxetine Hcl44$1,256
Gabapentin43$1,179
Omeprazole59$630
Albuterol Sulfate HfaAlbuterol Sulfate39$564
Lisinopril71$518
Ezetimibe25$513
Ibandronate Sodium14$502
Pravastatin Sodium29$489
Trazodone Hcl43$425
Atorvastatin Calcium62$411
Meloxicam41$399
Levothyroxine Sodium44$397

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$362$23,15114 claims
Lilly USA, LLCTrulicity$108$15,98213 claims
Johnson & JohnsonXarelto$14$5,99112 claims
Almatica Pharma LLCSertraline Hcl$125$35033 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →